{
  "ticker": "LLY",
  "target_date": "2025-04-30",
  "actual_date": "2025-04-30",
  "collected_at": "2025-12-08T11:42:22.716528",
  "price": {
    "open": 883.14,
    "high": 897.36,
    "low": 877.1,
    "close": 893.8323364257812,
    "volume": 4374100,
    "change_1d_pct": 1.55,
    "change_7d_pct": 9.89,
    "change_30d_pct": 9.29
  },
  "technicals": {
    "rsi_14": 73.14,
    "sma_20": 793.93,
    "sma_50": 829.95,
    "macd": 18.761,
    "macd_signal": 2.292,
    "macd_histogram": 16.469,
    "bb_upper": 917.94,
    "bb_lower": 669.92,
    "price_vs_sma20_pct": 12.58,
    "price_vs_sma50_pct": 7.7,
    "volume_ratio": 1.08
  },
  "fundamentals": {
    "market_cap": 890472955904,
    "pe_ratio": 48.668545,
    "forward_pe": 43.836056,
    "price_to_book": 37.399284,
    "price_to_sales": 14.986132,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.67,
    "pct_from_52w_low": 59.24
  },
  "macro": {
    "spy": {
      "price": 551.38,
      "change_1d_pct": 0.04,
      "change_7d_pct": 5.18
    },
    "vix": {
      "level": 24.7,
      "signal": "ELEVATED"
    },
    "treasury_10y": {
      "yield_pct": 4.18
    },
    "dollar_index": {
      "level": 99.47
    },
    "gold": {
      "price": 3305.0
    },
    "regime": "SIDEWAYS"
  },
  "news": [
    {
      "headline": "Amazon and Apple earnings coverage, Eli Lilly: What to Watch",
      "source": "Yahoo",
      "datetime": 1746054052,
      "summary": "Market Domination Overtime hosts Julie Hyman and Josh Lipton preview several of the biggest stories and reports due out tomorrow, Thursday, May 1, including Apple (AAPL) and Amazon's (AMZN) respective quarterly earnings results alongside Eli Lilly (LLY), Mastercard (MA), McDonald's (MCD), and CVS He",
      "url": "https://finnhub.io/api/news?id=df2b9307b9d5d0e211a07c09f4c5130fc294ec295df18da85e79cbabe9ceb01d"
    },
    {
      "headline": "Buy Hims (HIMS) or Novo Nordisk (NVO) Stock After Partnership Announcement?",
      "source": "Yahoo",
      "datetime": 1746046080,
      "summary": "Medical pioneers Hims & Hers Health (HIMS) and Novo Nordisk (NVO) are making headlines this week after announcing a partnership to expand obesity care in the telehealth space.",
      "url": "https://finnhub.io/api/news?id=050d35b07ee9fba24431dd4b29cc4fc87883821e38242e62e934b4ea12ffd412"
    },
    {
      "headline": "Eli Lilly\u2019s Earnings Report Will Bring a Focus on Tariffs, Not Profits",
      "source": "Yahoo",
      "datetime": 1746045120,
      "summary": "Eli Lilly  virtually alone among its large-cap pharma peers, has been having an excellent year.  The stock is up by a double-digit percentage since the start of 2025, its market value is the largest in the healthcare sector, and it looks increasingly as though it has the weight-loss market firmly in",
      "url": "https://finnhub.io/api/news?id=f77f1d5e41d36ea12c6aadfe73553220e9ceadbf3ce9348a8a3bcb002bcdbf5d"
    },
    {
      "headline": "Viagra and Mounjaro panic-buying could be behind a 200% export surge from Ireland to the U.S.",
      "source": "Yahoo",
      "datetime": 1746012325,
      "summary": "U.S. multinational activity propelled the Irish economy to 3.2% growth in the first quarter, as Trump fears come into focus.",
      "url": "https://finnhub.io/api/news?id=0807be49c23cd806d62aa662f7a5de11a9e63fe8a3f70fb66f655b6df02bb922"
    },
    {
      "headline": "Eli Lilly to lead oligonucleotide therapy development in new collaboration",
      "source": "Finnhub",
      "datetime": 1746009140,
      "summary": "Eli Lilly and Company and Creyon Bio, Inc. have agreed to collaborate to advance novel RNA-targeted oligonucleotide therapies for both rare and common diseases.Under an exclusive license from Creyon,...",
      "url": "https://finnhub.io/api/news?id=717347b45d7476fb55f1041dddc9ba91a6a20ed6c7a0e8a2482818bc12af0def"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-04-22",
      "description": "xslF345X05/wk-form4_1745353361.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000124/xslF345X05/wk-form4_1745353361.xml"
    },
    {
      "form": "4",
      "date": "2025-04-22",
      "description": "xslF345X05/wk-form4_1745353273.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000122/xslF345X05/wk-form4_1745353273.xml"
    },
    {
      "form": "4",
      "date": "2025-04-22",
      "description": "xslF345X05/wk-form4_1745353160.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000120/xslF345X05/wk-form4_1745353160.xml"
    },
    {
      "form": "4",
      "date": "2025-04-22",
      "description": "xslF345X05/wk-form4_1745352964.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000118/xslF345X05/wk-form4_1745352964.xml"
    },
    {
      "form": "4",
      "date": "2025-04-22",
      "description": "xslF345X05/wk-form4_1745352850.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000116/xslF345X05/wk-form4_1745352850.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}